menu search

Acadia pharmaceuticals (acad) reports q4 loss, tops revenue estimates

Acadia (ACAD) delivered earnings and revenue surprises of -4% and 1.55%, respectively, for the quarter ended December 2022. Do the numbers hold clues ...

February 27, 2023, 6:49 pm

Biomarin pharmaceutical (bmrn) q4 earnings lag estimates

BioMarin (BMRN) delivered earnings and revenue surprises of -7.69% and 0.69%, respectively, for the quarter ended December 2022. Do the numbers hold c...

February 27, 2023, 6:49 pm

Bausch + lomb: brent saunders return bodes well for shareholders

Brent Saunders led Bausch + Lomb Corporation when it was sold to Valeant pharmaceuticals. He later led ...

February 27, 2023, 5:22 pm

Ironwood pharmaceuticals to participate in upcoming investor conferences

BOSTON--(BUSINESS WIRE)--Ironwood pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company...

February 27, 2023, 4:01 pm

Cullinan oncology to participate in cowen’s 43rd annual health care conference

CAMBRIDGE, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan Oncology”) a bio...

February 27, 2023, 1:00 pm

Reata stock plummets as official's exit shakes up fda's neuroscience unit

The FDA will decide whether to approve a neurological disease drug from Reata pharmaceuticals this week...

February 27, 2023, 12:47 pm

Omniab: legitimate competition to abcellera in antibody discovery

OmniAb recently completed its separation from Ligand pharmaceuticals and is now a publicly traded indep...

February 27, 2023, 12:16 pm

Is bellicum pharmaceuticals (blcm) outperforming other medical stocks this year?

Here is how Bellicum pharmaceuticals (BLCM) and Castle Biosciences, Inc. (CSTL) have performed compared...

February 27, 2023, 11:17 am

Scholar rock to present at the cowen 43rd annual health care conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical...

February 27, 2023, 8:00 am

Calliditas: underfollowed swedish biotech focusing on rare kidney disease

Calliditas Therapeutics is a commercial-stage biopharmaceutical company based in Sweden focused on deve...

February 27, 2023, 1:41 am

This pharmaceuticals company looks to be a better pick over procter & gamble stock

There is more to the comparison, and in the sections below, we discuss the possible returns for P&G and AbbVie in the next three years....

February 27, 2023, 1:26 am

Hikma pharmaceuticals plc (hkmpf) q4 2022 earnings call transcript

Hikma pharmaceuticals PLC (OTCPK:HKMPF) Q4 2022 Earnings Conference Call February 23, 2023 6:00 AM ET C...

February 26, 2023, 1:13 pm

Why apellis pharmaceuticals stock surged this week

A highly eventful five days for the company saw bulls pile into its shares....

February 24, 2023, 6:08 pm

Agios pharmaceuticals (agio) moves to strong buy: rationale behind the upgrade

Agios pharmaceuticals (AGIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing opti...

February 24, 2023, 1:33 pm

Opko health (opk) q4 earnings match estimates, revenues top

Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in pharmaceuticals segment, its overall ...

February 24, 2023, 12:03 pm

Why is timber pharmaceuticals (tmbr) stock up 61% today?

Timber pharmaceuticals (NYSEMKT: TMBR ) stock is taking off on Friday after getting an orphan drug desi...

February 24, 2023, 11:57 am

Why obseva (obsv) stock is down 36% today

ObsEva (NASDAQ: OBSV ) is trending on social media, and OBSV stock is tumbling 36% to 10.85 cents. The Swiss bio...

February 24, 2023, 10:54 am

Alnylam (alny) q4 earnings top, product sales boost revenues

Alnylam pharmaceuticals (ALNY) reports better-than-expected fourth-quarter 2022 results. Total revenues...

February 24, 2023, 10:32 am

Sellas life sciences raises $20 million from public offering of stock, warrants

Sellas Life Sciences Group Inc. SLS, -3.40% said Friday that it raised $20.0 million, through the public sale of common shares and warrants to buy sto...

February 24, 2023, 8:42 am

Why is sellas life sciences (sls) stock down 38% today?

SELLAS Life Sciences (NASDAQ: SLS ) stock is falling on Friday after the late-stage clinical biopharmaceutical...

February 24, 2023, 8:29 am


Search within

Pages Search Results: